0.031108
0.000000
0.012166
0.000000
0.109577
0.000000
0.000000
0.000000
0.028270
0.00000
0.00000
0.00000
Bunkoczi, G.
Schiell, M.
Vertesy, L.
Sheldrick, G.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
111.36
90.00
32.146
9.126
37.982
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C2 H3 O2 -1
59.044
ACETATE ION
non-polymer
C4 H9 N O2
103.120
n
ALPHA-AMINOISOBUTYRIC ACID
L-peptide linking
C5 H11 N O2
117.146
D-ISOVALINE
D-peptide linking
C2 H6 O
46.068
ETHANOL
non-polymer
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
H2 O
18.015
WATER
non-polymer
C5 H9 N O3
131.130
n
4-HYDROXYPROLINE
HYDROXYPROLINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C9 H13 N O
151.206
n
L-PHENYLALANINOL
bound form of Phenylalaninal
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
UK
J.Pept.Sci.
JPSIEI
1225
1075-2617
9
745
10.1002/PSC.496
14658793
Crystal Structures of Cephaibols
2003
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100.0
1
MIRRORS
CCD
2002-05-15
BRUKER SMART 6000
SINGLE WAVELENGTH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
BRUKER M06XCE
1669.017
CEPHAIBOL B
2
nat
polymer
46.068
ETHANOL
2
syn
non-polymer
59.044
ACETATE ION
1
syn
non-polymer
18.015
water
26
nat
water
no
yes
(ACE)F(AIB)(AIB)(AIB)(DIV)GL(DIV)(AIB)(HYP)Q(DIV)(HYP)(AIB)P(PHL)
XFAAAVGLVAPQVPAPF
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
146077
ACREMONIUM TUBAKII
1
1.54
20
4.60
0.1 M NAAC/HAC PH=4.6, 32% ETOH, pH 4.60
diffrn_detector
chem_comp
refine
struct_conn
repository
Initial release
Atomic model
Database references
Derived calculations
Structure summary
Version format compliance
Other
Data collection
Data collection
Derived calculations
Refinement description
Structure summary
1
0
2003-12-11
1
1
2011-07-13
1
2
2012-11-30
1
3
2018-05-30
1
4
2019-05-22
_diffrn_detector.type
_chem_comp.pdbx_synonyms
_refine.pdbx_ls_cross_valid_method
_struct_conn.pdbx_leaving_atom_flag
CRYSTAL STRUCTURE OF THE PEPTAIBOL TRICHOTOXIN_A50E
SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB IN METHANOL
SOLUTION STRUCTURE OF THE PEPTIABOL ZERVAMICIN IIB
SOLUTION STRUCTURE OF THE PEPTAIBOL ZERVAMICIN IIB BOUND TO DPC MICELLES
SOLUTION STRUCTURE OF THE PEPTAIBOL ANTIAMOEBIN I
CRYSTAL STRUCTURE OF THE PEPTAIBOL ANTIAMOEBIN I
CRYSTAL STRUCTURE OF THE PEPTAIBOL ALAMETHICIN
SOLUTION STRUCTURE OF THE PEPTAIBOL CHRYSOSPERMIN C BOUND TO DPC MICELLES
CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL C
CRYSTAL STRUCTURE OF THE PEPTAIBOL CEPHAIBOL A
PDBE
Y
PDBE
2003-01-24
REL
EOH
ETHANOL
ACT
ACETATE ION
HOH
water
CEPHAIBOL B IS LINEAR PEPTIDE, A MEMBER OF THE PEPTAIBOL
FAMILY OF MEMBRANE CHANNEL FORMING PEPTIDES.
HERE, CEPHAIBOL B IS REPRESENTED BY THE SEQUENCE (SEQRES)
GROUP: 1
NAME: CEPHAIBOL B
CHAIN: A, B
COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 0 TO 16
DESCRIPTION: CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0)
Antibiotic
CEPHAIBOL A IS A HEXADECAMERIC HELICAL PEPTIDE.
THE N-TERM IS ACETYLATED (RESIDUE 0)
Cephaibol B
Peptaibol
EOH
29
2
EOH
EOH
29
A
ACT
29
3
ACT
ACT
29
B
EOH
30
2
EOH
EOH
30
B
HOH
2001
4
HOH
HOH
2001
A
HOH
2002
4
HOH
HOH
2002
A
HOH
2003
4
HOH
HOH
2003
A
HOH
2004
4
HOH
HOH
2004
A
HOH
2005
4
HOH
HOH
2005
A
HOH
2006
4
HOH
HOH
2006
A
HOH
2007
4
HOH
HOH
2007
A
HOH
2008
4
HOH
HOH
2008
A
HOH
2009
4
HOH
HOH
2009
A
HOH
2010
4
HOH
HOH
2010
A
HOH
2011
4
HOH
HOH
2011
A
HOH
2012
4
HOH
HOH
2012
A
HOH
2013
4
HOH
HOH
2013
A
HOH
2014
4
HOH
HOH
2014
A
HOH
2001
4
HOH
HOH
2001
B
HOH
2002
4
HOH
HOH
2002
B
HOH
2003
4
HOH
HOH
2003
B
HOH
2004
4
HOH
HOH
2004
B
HOH
2005
4
HOH
HOH
2005
B
HOH
2006
4
HOH
HOH
2006
B
HOH
2007
4
HOH
HOH
2007
B
HOH
2008
4
HOH
HOH
2008
B
HOH
2009
4
HOH
HOH
2009
B
HOH
2010
4
HOH
HOH
2010
B
HOH
2011
4
HOH
HOH
2011
B
HOH
2012
4
HOH
HOH
2012
B
ACE
0
n
1
ACE
0
A
PHE
1
n
2
PHE
1
A
AIB
2
n
3
AIB
2
A
AIB
3
n
4
AIB
3
A
AIB
4
n
5
AIB
4
A
DIV
5
n
6
DIV
5
A
GLY
6
n
7
GLY
6
A
LEU
7
n
8
LEU
7
A
DIV
8
n
9
DIV
8
A
AIB
9
n
10
AIB
9
A
HYP
10
n
11
HYP
10
A
GLN
11
n
12
GLN
11
A
DIV
12
n
13
DIV
12
A
HYP
13
n
14
HYP
13
A
AIB
14
n
15
AIB
14
A
PRO
15
n
16
PRO
15
A
PHL
16
n
17
PHL
16
A
ACE
0
n
1
ACE
0
B
PHE
1
n
2
PHE
1
B
AIB
2
n
3
AIB
2
B
AIB
3
n
4
AIB
3
B
AIB
4
n
5
AIB
4
B
DIV
5
n
6
DIV
5
B
GLY
6
n
7
GLY
6
B
LEU
7
n
8
LEU
7
B
DIV
8
n
9
DIV
8
B
AIB
9
n
10
AIB
9
B
HYP
10
n
11
HYP
10
B
GLN
11
n
12
GLN
11
B
DIV
12
n
13
DIV
12
B
HYP
13
n
14
HYP
13
B
AIB
14
n
15
AIB
14
B
PRO
15
n
16
PRO
15
B
PHL
16
n
17
PHL
16
B
0.0709
0.0746
0.0706
0.0744
0.0756
0.0793
738
778
5
5
14248
author_and_software_defined_assembly
PQS
1
monomeric
author_and_software_defined_assembly
PQS
1
monomeric
A
AIB
2
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
3
ALA
A
AIB
3
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
4
ALA
A
AIB
4
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
5
ALA
A
AIB
9
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
10
ALA
A
HYP
10
4-HYDROXYPROLINE
A
HYP
11
PRO
A
HYP
13
4-HYDROXYPROLINE
A
HYP
14
PRO
A
AIB
14
ALPHA-AMINOISOBUTYRIC ACID
A
AIB
15
ALA
A
PHL
16
L-PHENYLALANINOL
A
PHL
17
PHE
B
AIB
2
ALPHA-AMINOISOBUTYRIC ACID
B
AIB
3
ALA
B
AIB
3
ALPHA-AMINOISOBUTYRIC ACID
B
AIB
4
ALA
B
AIB
4
ALPHA-AMINOISOBUTYRIC ACID
B
AIB
5
ALA
B
AIB
9
ALPHA-AMINOISOBUTYRIC ACID
B
AIB
10
ALA
B
HYP
10
4-HYDROXYPROLINE
B
HYP
11
PRO
B
HYP
13
4-HYDROXYPROLINE
B
HYP
14
PRO
B
AIB
14
ALPHA-AMINOISOBUTYRIC ACID
B
AIB
15
ALA
B
PHL
16
L-PHENYLALANINOL
B
PHL
17
PHE
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
-9.65
1.20
120.10
110.45
B
B
B
CZ
CE2
CD2
PHE
PHE
PHE
1
1
1
B
B
B
N
0.0793
0.0746
0.0744
0.89
35.4
3121
778
16045
4640
5
97.0
THIN SHELLS
1
FREE R-VALUE
0.0
DIRECT METHODS
RESTRAINTS FOR AIB, DIV, HYP AND PHL FROM ANTIAMOEBIN (PDB 1JOH)
ENGH AND HUBER
MOEWS & KRETSINGER
10
252
267.5
0.89
35.4
26
276
10
0
240
0.021
0.040
0.012
0.505
0.131
0.093
0.050
0.006
0.040
0.890
35.400
1OB6
16045
0.04370
1
23.2900
4.440
97.0
0.07860
0.89
1.00
10.370
1
2.16
90.0
refinement
SHELXL-97
data reduction
SAINT
data scaling
SADABS
phasing
SHELXD
CEPHAIBOL B
Cephaibol B
1
N
N
1
N
N
2
N
N
3
N
N
2
N
N
4
N
N
4
N
N
A
PHE
1
A
PHE
2
HELX_P
A
HYP
10
A
HYP
11
1
1
10
B
PHE
1
B
PHE
2
HELX_P
B
AIB
9
B
AIB
10
1
2
9
B
HYP
10
B
HYP
11
HELX_P
B
DIV
12
B
DIV
13
5
3
3
covale
1.334
both
A
ACE
0
A
C
ACE
1
1_555
A
PHE
1
A
N
PHE
2
1_555
covale
1.348
both
A
PHE
1
A
C
PHE
2
1_555
A
AIB
2
A
N
AIB
3
1_555
covale
1.336
both
A
AIB
2
A
C
AIB
3
1_555
A
AIB
3
A
N
AIB
4
1_555
covale
1.342
both
A
AIB
3
A
C
AIB
4
1_555
A
AIB
4
A
N
AIB
5
1_555
covale
1.332
both
A
AIB
4
A
C
AIB
5
1_555
A
DIV
5
A
N
DIV
6
1_555
covale
1.336
both
A
DIV
5
A
C
DIV
6
1_555
A
GLY
6
A
N
GLY
7
1_555
covale
1.337
both
A
LEU
7
A
C
LEU
8
1_555
A
DIV
8
A
N
DIV
9
1_555
covale
1.336
both
A
DIV
8
A
C
DIV
9
1_555
A
AIB
9
A
N
AIB
10
1_555
covale
1.349
both
A
AIB
9
A
C
AIB
10
1_555
A
HYP
10
A
N
HYP
11
1_555
covale
1.335
both
A
HYP
10
A
C
HYP
11
1_555
A
GLN
11
A
N
GLN
12
1_555
covale
1.328
both
A
A
GLN
11
A
C
GLN
12
1_555
A
DIV
12
A
N
DIV
13
1_555
covale
1.330
both
B
A
GLN
11
A
C
GLN
12
1_555
A
DIV
12
A
N
DIV
13
1_555
covale
1.345
both
B
B
A
DIV
12
A
C
DIV
13
1_555
A
HYP
13
A
N
HYP
14
1_555
covale
1.363
both
A
A
A
DIV
12
A
C
DIV
13
1_555
A
HYP
13
A
N
HYP
14
1_555
covale
1.315
both
A
A
A
HYP
13
A
C
HYP
14
1_555
A
AIB
14
A
N
AIB
15
1_555
covale
1.322
both
B
B
A
HYP
13
A
C
HYP
14
1_555
A
AIB
14
A
N
AIB
15
1_555
covale
1.334
both
A
A
A
AIB
14
A
C
AIB
15
1_555
A
PRO
15
A
N
PRO
16
1_555
covale
1.351
both
B
B
A
AIB
14
A
C
AIB
15
1_555
A
PRO
15
A
N
PRO
16
1_555
covale
1.303
both
B
B
A
PRO
15
A
C
PRO
16
1_555
A
PHL
16
A
N
PHL
17
1_555
covale
1.299
both
A
A
A
PRO
15
A
C
PRO
16
1_555
A
PHL
16
A
N
PHL
17
1_555
covale
1.357
both
A
A
B
ACE
0
B
C
ACE
1
1_555
B
PHE
1
B
N
PHE
2
1_555
covale
1.296
both
B
B
B
ACE
0
B
C
ACE
1
1_555
B
PHE
1
B
N
PHE
2
1_555
covale
1.347
both
B
B
B
PHE
1
B
C
PHE
2
1_555
B
AIB
2
B
N
AIB
3
1_555
covale
1.341
both
A
A
B
PHE
1
B
C
PHE
2
1_555
B
AIB
2
B
N
AIB
3
1_555
covale
1.339
both
A
A
B
AIB
2
B
C
AIB
3
1_555
B
AIB
3
B
N
AIB
4
1_555
covale
1.329
both
B
B
B
AIB
2
B
C
AIB
3
1_555
B
AIB
3
B
N
AIB
4
1_555
covale
1.340
both
B
AIB
3
B
C
AIB
4
1_555
B
AIB
4
B
N
AIB
5
1_555
covale
1.335
both
B
AIB
4
B
C
AIB
5
1_555
B
DIV
5
B
N
DIV
6
1_555
covale
1.347
both
B
DIV
5
B
C
DIV
6
1_555
B
GLY
6
B
N
GLY
7
1_555
covale
1.339
both
B
LEU
7
B
C
LEU
8
1_555
B
DIV
8
B
N
DIV
9
1_555
covale
1.355
both
B
DIV
8
B
C
DIV
9
1_555
B
AIB
9
B
N
AIB
10
1_555
covale
1.347
both
B
AIB
9
B
C
AIB
10
1_555
B
HYP
10
B
N
HYP
11
1_555
covale
1.333
both
B
HYP
10
B
C
HYP
11
1_555
B
GLN
11
B
N
GLN
12
1_555
covale
1.336
both
B
GLN
11
B
C
GLN
12
1_555
B
DIV
12
B
N
DIV
13
1_555
covale
1.360
both
B
DIV
12
B
C
DIV
13
1_555
B
HYP
13
B
N
HYP
14
1_555
covale
1.313
both
B
HYP
13
B
C
HYP
14
1_555
B
AIB
14
B
N
AIB
15
1_555
covale
1.357
both
B
AIB
14
B
C
AIB
15
1_555
B
PRO
15
B
N
PRO
16
1_555
covale
1.316
both
B
PRO
15
B
C
PRO
16
1_555
B
PHL
16
B
N
PHL
17
1_555
ANTIBIOTIC
CEPHAIBOL, PEPTAIBOL, ANTIBACTERIAL, ANTIFUNGAL, ION CHANNEL, ANTIBIOTIC
given
0.994460
0.016940
0.103710
-0.016340
0.999840
-0.006660
-0.103810
0.004930
0.994580
19.39953
5.28985
-19.99939
NOR00971
NOR
1
NOR00971
0
16
1OB6
0
16
NOR00971
A
1
1
17
0
16
1OB6
0
16
NOR00971
B
1
1
17
BINDING SITE FOR RESIDUE ACT B 29
Software
3
BINDING SITE FOR RESIDUE EOH A 29
Software
4
BINDING SITE FOR RESIDUE EOH B 30
Software
4
BINDING SITE FOR CHAIN A OF CEPHAIBOL B
Software
26
BINDING SITE FOR CHAIN B OF CEPHAIBOL B
Software
25
A
PHE
1
A
PHE
2
3
1_446
B
PRO
15
B
PRO
16
3
1_555
B
EOH
30
E
EOH
3
1_555
A
GLY
6
A
GLY
7
4
1_555
A
HYP
10
A
HYP
11
4
1_555
A
HOH
2001
F
HOH
4
1_565
A
HOH
2006
F
HOH
4
1_555
A
ACE
0
A
ACE
1
4
1_446
B
PHL
16
B
PHL
17
4
1_545
B
ACT
29
D
ACT
4
1_555
B
HOH
2011
G
HOH
4
1_545
A
EOH
29
C
EOH
26
1_555
A
HOH
2001
F
HOH
26
1_555
A
HOH
2004
F
HOH
26
1_555
A
HOH
2005
F
HOH
26
1_555
A
HOH
2005
F
HOH
26
1_545
A
HOH
2006
F
HOH
26
1_555
A
HOH
2007
F
HOH
26
1_555
A
HOH
2008
F
HOH
26
1_545
A
HOH
2008
F
HOH
26
1_555
A
HOH
2009
F
HOH
26
1_555
A
HOH
2010
F
HOH
26
1_555
A
HOH
2011
F
HOH
26
1_565
A
HOH
2011
F
HOH
26
1_555
A
HOH
2012
F
HOH
26
1_555
A
HOH
2013
F
HOH
26
1_555
B
ACE
0
B
ACE
1
26
1_565
B
ACE
0
B
ACE
1
26
1_555
B
PHE
1
B
PHE
2
26
1_555
B
AIB
2
B
AIB
3
26
1_555
B
AIB
14
B
AIB
15
26
1_664
B
PRO
15
B
PRO
16
26
1_664
B
PHL
16
B
PHL
17
26
1_664
B
ACT
29
D
ACT
26
1_664
B
EOH
30
E
EOH
26
1_664
B
HOH
2001
G
HOH
26
1_565
B
HOH
2011
G
HOH
26
1_654
A
ACE
0
A
ACE
1
25
1_446
A
PHE
1
A
PHE
2
25
1_446
A
AIB
2
A
AIB
3
25
1_446
A
AIB
14
A
AIB
15
25
1_555
A
PRO
15
A
PRO
16
25
1_555
A
PHL
16
A
PHL
17
25
1_545
A
PHL
16
A
PHL
17
25
1_555
A
HOH
2002
F
HOH
25
1_555
A
HOH
2012
F
HOH
25
1_555
A
HOH
2013
F
HOH
25
1_555
A
HOH
2014
F
HOH
25
1_555
B
ACT
29
D
ACT
25
1_555
B
EOH
30
E
EOH
25
1_565
B
HOH
2002
G
HOH
25
1_555
B
HOH
2003
G
HOH
25
1_555
B
HOH
2004
G
HOH
25
1_555
B
HOH
2005
G
HOH
25
1_555
B
HOH
2006
G
HOH
25
1_555
B
HOH
2007
G
HOH
25
1_545
B
HOH
2007
G
HOH
25
1_555
B
HOH
2008
G
HOH
25
1_555
B
HOH
2009
G
HOH
25
1_555
B
HOH
2010
G
HOH
25
1_555
B
HOH
2011
G
HOH
25
1_555
B
HOH
2012
G
HOH
25
1_555
4
P 1 21 1